Novel approaches for assessing patients with chest pain and related symptoms may improve outpatient care. The REGISTRY I study measured the impact of a personalized gene expression score (GES) on subsequent cardiac referral decisions by primary care providers. Of the 342 stable, nonacute patients evaluated, the mean age was 55 years, 53% were female, and mean (SD) GES was 16 (±10) (range = 1-40). Low GES (≤15), indicating a low current likelihood of obstructive coronary artery disease (CAD), was observed in 49% of patients. After clinical covariate adjustment, each 10-point GES decrease was associated with a 14-fold decreased odds of cardiac referral (P < .0001). Low GES patients had 94% reduced odds of referral relative to elevated GES patients (P < .0001), with follow-up supporting a favorable safety profile. This genomic-based test demonstrated clinical utility by guiding decision making during assessment of symptomatic patients with suspected obstructive CAD.
CayleyWEJr.Diagnosing the cause of chest pain. Am Fam Physician. 2005;72:2012-2021.
2.
RogerVIGoALoyd-JonesDM; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Executive summary: heart disease and stroke statistics—2012 update: a report from the American Heart Association. Circulation. 2012;125:188-197.
Centers for Disease Control and Prevention. National Center for Health Statistics, United States, 2008, with Chartbook. Hyattsville, MD: National Center for Health Statistics; 2009.
5.
BruyninckRVan den BruelAHannesKBuntinxFAertgeertsB. GPs’ reasons for referral of patients with chest pain: a qualitative study. BMC Fam Pract. 2009;31(10):55.
6.
WackersFZaretB. Radionuclide stress myocardial perfusion imaging: the future gatekeeper for coronary angiography. J Nucl Cardiol. 1995;2:358-359.
7.
ShawLJMieresJH. The role of noninvasive testing in the diagnosis and prognosis of women with suspected CAD. J Fam Pract. 2005;(suppl):4-5.
8.
SistromCMcKayNWeilburgJAtlasSFerrisT. Determinants of diagnostic imaging utilization in primary care. Am J Manag Care. 2012;18(4):e135-e144.
9.
CarlisleDLeapeLBickelS. Underuse and overuse of diagnostic testing for coronary artery disease in patients presenting with new-onset chest pain. Am J Med. 1999;106:391-398.
10.
FoyARierJKozakM. High numbers of false-positive stress tests are the result of inappropriate testing. Am J Med Qual. 2014;29:153-159.
11.
BallardDJLeonardBM. National priorities partnership focus on eliminating overuse: applications to cardiac revascularization. Am J Med Qual. 2011;26:485-490.
12.
PatelMRPetersonEDDaiD. Low diagnostic yield of elective coronary angiography. N Engl J Med. 2010;362:886-895.
13.
RozanskiAGransarHHayesSW. Temporal trends in the frequency of inducible myocardial ischemia during cardiac stress testing: 1991 to 2009. J Am Coll Cardiol. 2013;61:1054-1065.
14.
KlinkmanMSStevensDGorenfloDW. Episodes of care for chest pain: a preliminary report from MIRNET. Michigan Research Network. J Fam Pract. 1994;38:345-352.
15.
KaterndahlDA. Panic plaques: panic disorder & coronary artery disease in patients with chest pain. J Am Board Fam Pract. 2004;17:114-126.
16.
US Government Printing Office. Medicare Program; Payment Policies Under the Physician Fee Schedule, Five-Year Review of Work Relative Value Units, Clinical Laboratory Fee Schedule: Signature on Requisition, and Other Revisions to Part B for CY 2012. http://www.gpo.gov/fdsys/granule/FR-2011-11-28/2011-28597/content-detail.html. Accessed March 28, 2014.
17.
AyyadAColeJSyedA. Temporal trends in utilization of cardiac computed tomographyJ Cardiovasc Comput Tomogr. 2009;3(1):16-21.
18.
ShawLJHachamovitchRBermanDS. The economic consequences of available diagnostic and prognostic strategies for the evaluation of stable angina patients: an observational assessment of the value of precatheterization ischemia. Economics of Noninvasive Diagnosis (END) Multicenter Study Group. J Am Coll Cardiol. 1999;33:661-669.
19.
EinsteinAMoserKWThompsonRCCerqueiraMDHenzlovaMJ. Radiation dose to patients from cardiac diagnostic imaging. Circulation. 2007;116:1290-1305.
20.
EinsteinAJWeinerSDBernheimA. Multiple testing, cumulative radiation dose, and clinical indications in patients undergoing myocardial perfusion imaging. JAMA. 2010;304:2137-2144.
21.
RheeCBhanIAlexanderEKBrunelliSM. Association between iodinated contrast media exposure and incident hyperthyroidism and hypothyroidism. Arch Intern Med. 2012;172:153-159.
22.
LadapoJABleckerSElashoffMR. Clinical implications of referral bias in the diagnostic performance of exercise testing for coronary artery disease. J Am Heart Assoc. 2013;2(6):e000505.
ChengVYBermanDSRozanskiA. Performance of the traditional age, sex, and angina typicality-based approach for estimating pretest probability of angiographically significant coronary artery disease in patients undergoing coronary computed tomographic angiography: results from the multinational coronary CT angiography evaluation for clinical outcomes: an international multicenter registry (CONFIRM). Circulation. 2011;124:2423-2432.
26.
RosenbergSElashoffMRBeinekeP. Multicenter validation of the diagnostic accuracy of a blood-based gene expression test for assessing obstructive coronary artery disease in nondiabetic patients. Ann Intern Med. 2010;153:425-434.
27.
ThomasGVorosSMcPhersonJ. A blood-based gene expression test for obstructive coronary artery disease tested in symptomatic non-diabetic patients referred for myocardial perfusion imaging: the COMPASS study. Circ Cardiovasc Genet. 2013;6:154-162.
28.
HigashiMKVeenstraDL. Managed care in the genomics era: assessing the cost effectiveness of genetic tests. Am J Manag Care. 2003;9:493-500.
29.
ElashoffMRWingroveJABeinekeP. Development of a blood-based gene expression algorithm for assessment of obstructive coronary artery disease in non-diabetic patients. BMC Med Genomics. 2011;4(1):26.
30.
LanskyAElashoffMRNgV. A gender-specific blood-based gene expression score for assessing obstructive coronary artery disease in nondiabetic patients: results of the Personalized Risk Evaluation and Diagnosis in the Coronary Tree (PREDICT) trial. Am Heart J. 2012;164:320-326.
31.
US Government Accountability Office. Rapid spending growth and shift to physician offices indicate need for CMS to consider additional management practices (GAO-08-452). http://www.gao.gov/products/GAO-08-452. Accessed March 2, 2014.
32.
OteroHJRybickiFJGreenbergDMitsourasDMendozaJANeumannPJ. Cost-effective diagnostic cardiovascular imaging: when does it provide good value for the money?Int J Cardiovasc Imaging. 2010;26:605-612.
33.
LadapoJAHorwitzJRWeinsteinMCGazelleGSCutlerDM. Adoption and spread of new imaging technology: a case study. Health Aff (Millwood). 2009;28(6):w1122-w1132.
34.
HermanLFroelichJKanelosD. Improved patterns for advanced non-invasive diagnostic testing using a personalized gene expression score among patients presenting to primary care clinicians with symptoms of suspected obstructive coronary artery disease: results from the IMPACT PCP (Investigation of a Molecular Personalized Coronary Gene Expression Test on Primary Care Practice Pattern) Trial. J Am Board Fam Med. In press.
35.
RosenbergSElashoffMRLieuHD. Whole blood gene expression testing for coronary artery disease in nondiabetic patients: major adverse cardiovascular events and interventions in the PREDICT Trial. J Cardiovasc Transl Res. 2012;5:366-374.
36.
McPhersonJADavisKYauM. Gene expression testing improves the diagnostic evaluation of patients presenting to the cardiologist with symptoms of suspected obstructive coronary artery disease: results from the IMPACT (Investigation of a Molecular Personalized Coronary Gene Expression Test on Cardiology Practice Pattern) trial. Crit Pathw Cardiol. 2013;12(2):37-42.
37.
HochheiserLIJuusolaJLMonaneMLadapoJA. Economic utility of a blood-based genomic test for the assessment of patients with symptoms suggestive of obstructive coronary artery disease [published online February 25, 2014]. Popul Health Manag. doi:10.1089/pop.2013.0096.
38.
PhelpsCEO’SullivanAKLadapoJAWeinsteinMCLeahyKDouglasPS. Cost effectiveness of a gene expression score and myocardial perfusion imaging for diagnosis of coronary artery disease. Am Heart J. In press.
